TY  - JOUR
AU  - Sánchez Sánchez, Roberto
AU  - Velasco Jiménez, Natalia
AU  - Arranz Solís, David
AU  - Criado, Miguel
AU  - Ferré Pérez, Ignacio
AU  - Re, Michela Tatiana
AU  - Hulverson, Matthew A.
AU  - Choi, Ryan
AU  - Barrett, Lynn K.
AU  - Hemphill, Andrew
AU  - Van Voorhis, Wesley C.
AU  - Ortega Mora, Luis Miguel
PY  - 2026
DO  - 10.3389/fcimb.2026.1819490
UR  - https://hdl.handle.net/20.500.14352/136780
T2  - Frontiers in Cellular and Infection Microbiology
AB  - Background: Unlike mouse models of congenital toxoplasmosis, pregnant sheep models provide the opportunity to evaluate treatment strategies that more closely resemble clinical practice in pregnant women, including chemotherapeutic interventions...
LA  - eng
M2  - 1
PB  - Frontiers Media
KW  - BKI-1748
KW  - Congenital toxoplasmosis
KW  - Efficacy
KW  - IgM
KW  - Sheep
KW  - Toxoplasma gondii,
KW  - Translational pharmaceutics
TI  - BKI-1748 confers a high level of protection against ovine congenital toxoplasmosis when administered after IgM seroconversion
TY  - journal article
VL  - 16
ER  -